311 related articles for article (PubMed ID: 29065733)
1. Hepatitis B core protein as a therapeutic target.
Mak LY; Wong DK; Seto WK; Lai CL; Yuen MF
Expert Opin Ther Targets; 2017 Dec; 21(12):1153-1159. PubMed ID: 29065733
[TBL] [Abstract][Full Text] [Related]
2. The current status and future directions of hepatitis B antiviral drug discovery.
Tang L; Zhao Q; Wu S; Cheng J; Chang J; Guo JT
Expert Opin Drug Discov; 2017 Jan; 12(1):5-15. PubMed ID: 27797587
[TBL] [Abstract][Full Text] [Related]
3. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
[TBL] [Abstract][Full Text] [Related]
4. New antivirals for the treatment of chronic hepatitis B.
Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
[TBL] [Abstract][Full Text] [Related]
5. Future anti-HBV strategies.
Gane EJ
Liver Int; 2017 Jan; 37 Suppl 1():40-44. PubMed ID: 28052637
[TBL] [Abstract][Full Text] [Related]
6. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus: new therapeutic perspectives.
Lin CL; Yang HC; Kao JH
Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
[TBL] [Abstract][Full Text] [Related]
8. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
9. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.
Guo F; Zhao Q; Sheraz M; Cheng J; Qi Y; Su Q; Cuconati A; Wei L; Du Y; Li W; Chang J; Guo JT
PLoS Pathog; 2017 Sep; 13(9):e1006658. PubMed ID: 28945802
[TBL] [Abstract][Full Text] [Related]
10. Novel targets for hepatitis B virus therapy.
Testoni B; Durantel D; Zoulim F
Liver Int; 2017 Jan; 37 Suppl 1():33-39. PubMed ID: 28052622
[TBL] [Abstract][Full Text] [Related]
11. Review article: novel therapies for hepatitis B virus cure - advances and perspectives.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2016 Aug; 44(3):213-22. PubMed ID: 27302653
[TBL] [Abstract][Full Text] [Related]
12. Emerging drugs for the treatment of hepatitis B.
Fung J; Lai CL; Seto WK; Yuen MF
Expert Opin Emerg Drugs; 2016 Jun; 21(2):183-93. PubMed ID: 26940510
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years.
Liu B; Wen X; Huang C; Wei Y
Int J Biochem Cell Biol; 2013 Sep; 45(9):1987-96. PubMed ID: 23819994
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
[TBL] [Abstract][Full Text] [Related]
15. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
Revill P; Locarnini S
Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.
Yang L; Liu F; Tong X; Hoffmann D; Zuo J; Lu M
ACS Infect Dis; 2019 May; 5(5):713-724. PubMed ID: 30896149
[TBL] [Abstract][Full Text] [Related]
17. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapeutics and relevant targets for chronic Hepatitis B.
Song IH
Turk J Gastroenterol; 2016 May; 27(3):210-5. PubMed ID: 27210776
[TBL] [Abstract][Full Text] [Related]
19. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
[TBL] [Abstract][Full Text] [Related]
20. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.
Nassal M
Gut; 2015 Dec; 64(12):1972-84. PubMed ID: 26048673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
